{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:49:00Z","timestamp":1782928140209,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03346-9","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:13:18Z","timestamp":1782925998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tissue factor-related biomarkers during combined androgen blockade in patients with prostate cancer: A brief report"],"prefix":"10.1007","author":[{"given":"Athanasios","family":"Klampatsas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Tsiatsiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevoula","family":"Koutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios A.","family":"Tsakiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemonia","family":"Skoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"16","key":"3346_CR1","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2025.0228","volume":"333","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri R, Lin DW, and;, Montgomery RB (2025) Prostate Cancer JAMA 333(16):1433\u20131446. https:\/\/doi.org\/10.1001\/jama.2025.0228","journal-title":"Prostate Cancer JAMA"},{"issue":"3","key":"3346_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/AJCO.13108","volume":"15","author":"D Fang","year":"2019","unstructured":"Fang D, Zhou L (2019) Androgen deprivation therapy in nonmetastatic prostate cancer patients: Indications, treatment effects, and new predictive biomarkers. Asia Pac J Clin Oncol\u00a015(3):\u00a0108\u2013120. https:\/\/doi.org\/10.1111\/AJCO.13108","journal-title":"Asia Pac J Clin Oncol"},{"issue":"6","key":"3346_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/CANCERS12061690","volume":"12","author":"M Murakami","year":"2020","unstructured":"Murakami M et al (2020) Optimal androgen deprivation therapy combined with proton beam therapy for prostate cancer: results from a multi-institutional study of the Japanese radiation oncology study group, Cancers 2020, 12(6): 1\u201310 https:\/\/doi.org\/10.3390\/CANCERS12061690","journal-title":"Cancers"},{"issue":"4","key":"3346_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/J.EURURO.2023.01.020","volume":"85","author":"LK Mell","year":"2024","unstructured":"Mell LK et al (2024) Effects of androgen deprivation therapy on prostate cancer outcomes according to competing event risk: secondary analysis of a phase 3 randomised trial. Eur. Urol. 85(4):373\u2013381. https:\/\/doi.org\/10.1016\/J.EURURO.2023.01.020","journal-title":"Eur. Urol."},{"issue":"1","key":"3346_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/AJA.AJA_22_20","volume":"23","author":"S Freedland","year":"2021","unstructured":"Freedland S, Abrahamsson PA (2021) Androgen deprivation therapy and side effects: are GnRH antagonists safer? Asian J. Androl. 23(1):3\u201310. https:\/\/doi.org\/10.4103\/AJA.AJA_22_20","journal-title":"Asian J. Androl."},{"key":"3346_CR6","doi-asserted-by":"publisher","first-page":"794310","DOI":"10.3389\/FCVM.2022.794310\/BIBTEX","volume":"9","author":"CS Hong","year":"2022","unstructured":"Hong CS et al (2022) Association of Gonadotropin-Releasing Hormone Therapies With Venous Thromboembolic Events in Patients With Prostate Cancer: A National Cohort Study. Front Cardiovasc Med 9:794310. https:\/\/doi.org\/10.3389\/FCVM.2022.794310\/BIBTEX","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"3346_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/S11912-023-01424-2","volume":"25","author":"J Kim","year":"2023","unstructured":"Kim J, Freeman K, Ayala A, Mullen MK, Sun Z, Rhee JW (2023) Cardiovascular impact of androgen deprivation therapy: from basic biology to clinical practice. Curr. Oncol. Rep. 25(9):965\u2013977. https:\/\/doi.org\/10.1007\/S11912-023-01424-2","journal-title":"Curr. Oncol. Rep."},{"issue":"Suppl","key":"3346_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000239","volume":"3","author":"D Mege","year":"2019","unstructured":"Mege D, Panicot-Dubois L, Dubois C (2019) Mechanisms of cancer-associated thrombosis. Hemasphere 3(Suppl):19-21. https:\/\/doi.org\/10.1097\/HS9.0000000000000239","journal-title":"Hemasphere"},{"key":"3346_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40364-023-00504-6","volume":"11","author":"SE Ahmadi","year":"2023","unstructured":"Ahmadi SE et al (2023) REVIEW Open Access Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer. Biomark Res 11:60. https:\/\/doi.org\/10.1186\/s40364-023-00504-6","journal-title":"Biomark Res"},{"key":"3346_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00932-z","author":"D Unruh","year":"2020","unstructured":"Unruh D, Horbinski C (2020) Beyond thrombosis: the impact of tissue factor signaling in cancer. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-020-00932-z","journal-title":"J. Hematol. Oncol."},{"key":"3346_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-023-43427-W","author":"X Lei","year":"2023","unstructured":"Lei X, Zhang T, Deng Z, Jiang T, Hu Y, Yang N (2023) Coagulation markers as independent predictors of prostate cancer aggressiveness: a retrospective cohort study. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-023-43427-W","journal-title":"Sci. Rep."},{"key":"3346_CR12","unstructured":"EAU Guidelines on Prostate Cancer - TREATMENT Accessed: Apr. 03, 2026. [Online]. Available: https:\/\/uroweb.org\/guidelines\/prostate%E2%80%90cancer\/chapter\/treatment"},{"key":"3346_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS14246164\/S1","author":"J Bas\u00edlio","year":"2022","unstructured":"Bas\u00edlio J et al (2022) Antagonistic Functions of Androgen Receptor and NF-\u03baB in Prostate Cancer\u2014Experimental and Computational Analyses. Cancers (Basel) 14(24). https:\/\/doi.org\/10.3390\/CANCERS14246164\/S1","journal-title":"Cancers (Basel)"},{"key":"3346_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/J.UROLOGY.2017.11.055","volume":"114","author":"KT Nead","year":"2018","unstructured":"Nead KT, Boldbaatar N, Yang DD, Sinha S, Nguyen PL (2018) Association of Androgen Deprivation Therapy and Thromboembolic Events: A Systematic Review and Meta-analysis. Urology 114:155\u2013162. https:\/\/doi.org\/10.1016\/J.UROLOGY.2017.11.055","journal-title":"Urology"},{"key":"3346_CR15","doi-asserted-by":"publisher","first-page":"107602962095428","DOI":"10.1177\/1076029620954282","volume":"26","author":"MS Hamza","year":"2020","unstructured":"Hamza MS, Mousa SA (2020) Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future Management. Clin Appl Thromb Hemost 26:1076029620954282. https:\/\/doi.org\/10.1177\/1076029620954282","journal-title":"Clin Appl Thromb Hemost"},{"issue":"10","key":"3346_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/CANCERS12102984","volume":"12","author":"M Archer","year":"2020","unstructured":"Archer M, Dogra N, Kyprianou N, Archer M, Dogra N, Kyprianou N (2020) Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance. Cancers 12(10):1\u201324. https:\/\/doi.org\/10.3390\/CANCERS12102984","journal-title":"Cancers"},{"issue":"23","key":"3346_CR17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.21037\/atm-22-5221","volume":"10","author":"L Wang","year":"2022","unstructured":"Wang L, Zhong J, Xiao D, Huang W, Zheng Z, Jiang Y (2022) Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-\u03b12-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study. Ann. Transl. Med. 10(23):1273","journal-title":"Ann. Transl. Med."},{"issue":"12","key":"3346_CR18","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1111\/jth.15529","volume":"19","author":"F Depasse","year":"2021","unstructured":"Depasse F et al (2021) Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine. Journal of Thrombosis and Haemostasis 19(12):2907\u20132917. https:\/\/doi.org\/10.1111\/jth.15529","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"12","key":"3346_CR19","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1111\/jth.15880","volume":"20","author":"F Moik","year":"2022","unstructured":"Moik F, Ay C (2022) Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer. Journal of Thrombosis and Haemostasis 20(12):2733\u20132745. https:\/\/doi.org\/10.1111\/jth.15880","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"3346_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS16112082","author":"AG Tsantes","year":"2024","unstructured":"Tsantes AG et al (2024) Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines. Cancers. https:\/\/doi.org\/10.3390\/CANCERS16112082","journal-title":"Cancers"},{"key":"3346_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS14071679.","author":"I AlZaim","year":"2022","unstructured":"AlZaim I et al (2022) Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue. Cancer. https:\/\/doi.org\/10.3390\/CANCERS14071679.","journal-title":"Cancer"},{"key":"3346_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS15071957","author":"H Jing","year":"2023","unstructured":"Jing H, Wu X, Xiang M, Wang C, Novakovic VA, Shi J (2023) Microparticle Phosphatidylserine Mediates Coagulation: Involvement in Tumor Progression and Metastasis. Cancers. https:\/\/doi.org\/10.3390\/CANCERS15071957","journal-title":"Cancers"},{"issue":"3","key":"3346_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1055\/A-1153-5824.","volume":"40","author":"S Reda","year":"2020","unstructured":"Reda S, Morimont L, Douxfils J, R\u00fchl H (2020) Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests? Hamostaseologie 40(3):364\u2013378. https:\/\/doi.org\/10.1055\/A-1153-5824.","journal-title":"Hamostaseologie"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03346-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03346-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03346-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:13:27Z","timestamp":1782926007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03346-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":23,"alternative-id":["3346"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03346-9","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from all the participants involved in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study was approved by the Theagenion Cancer Hospital Research Ethics Committee and the Bioethics Approval Committee of the Aristotle University (approval no. 2022-51-PC). All procedures performed on the patients complied with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}